1. ALLA AKTIER
  2. NYHETER
  3. QLUCORE

Qlucore

Nyheter Qlucore Nyheter alla bolag

Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics

Qlucore, a driving force in software development for precision diagnostics of cancer, has signed an agreement with Uppsala University Hospital. The hospital will use the Qlucore Insights software to improve the analysis of acute lymphoblastic leukemia (ALL) in children. ALL is the most common form of childhood leukemia - 90% of children who get leukemia are affected by ALL.

Qlucore already has customers in Denmark, Sweden, and Italy who use the software. The agreement for precision diagnostics will be the second signed in Sweden in a short time. The goal is to help customers develop analyses that contribute to a more accurate diagnosis and thus a better choice of treatment.
 
"Our solutions use AI-based machine learning and will facilitate and enable improved analysis of cancer, in this case acute lymphoblastic leukemia (ALL). The goal is to make it easier for doctors to make a diagnosis and decide how to treat the disease”, says Carl-Johan Ivarsson, CEO of Qlucore.
 
Cancer diagnostics are changing rapidly and Qlucore is at the forefront of this development. The unique software combines advanced visualization, mathematics, and biology. The company's advanced software creates the conditions for more precise cancer diagnostics where AI-based machine learning makes it possible to place a sample in the right subgroup.
 
 Qlucore Insights is available for research and work to achieve CE marking is ongoing. The CE-marked product will be called Qlucore Diagnostics.

Certified Advisor

FNCA Sweden AB
Web: www.fnca.se

Contacts

Press contact:
Michael Bull
Brookscomm
Phone: +44 (0) 1483 537 890
Email: michael@brookscomm.com

Qlucore contact:
Carl-Johan Ivarsson, CEO
Phone: +46 (0) 46 286 31 14
Email: carl-johan.ivarsson@qlucore.com 

About Qlucore

Qlucore is a leading provider of new generation intuitive bioinformatics software for research and precision and companion diagnostics. Qlucore’s mission is to make it easier to analyze the huge amounts of complex data generated by innovations in the fields of genomics and proteomics by providing powerful visualization-based bioinformatics data analysis tools for research and precision diagnostics. Qlucore Omics Explorer software is a easy to use bioinformatics software for research in the life science, plant- and biotech industries, as well as in academia. Qlucore Diagnostics and Qlucore Insights are software platforms with built in AI-based machine learning for multi-omics companion and precision diagnostics. Qlucore was founded in 2007 in Lund, Sweden and has customers in about 25 countries around the world, with sales offices in Europe and North America, and distribution in several countries in Asia. Qlucore is listed on the Nasdaq First North Growth market. www.qlucore.com

Image Attachments

ALL
PR 2024 05 Uppsala Sjukhus

Attachments

Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics

Datum 2024-05-29, kl 10:00
Källa MFN
Bifogade filer
Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics
ALL
PR 2024 05 Uppsala Sjukhus
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!